These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27734218)

  • 1. The importance of residual renal function in peritoneal dialysis.
    Sikorska D; Pawlaczyk K; Olewicz-Gawlik A; Czepulis N; Posnik B; Baum E; Wanic-Kossowska M; Lindholm B; Oko A
    Int Urol Nephrol; 2016 Dec; 48(12):2101-2108. PubMed ID: 27734218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.
    Alexandrou ME; Balafa O; Sarafidis P
    Am J Nephrol; 2020; 51(8):589-612. PubMed ID: 32721969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is N-terminal probrain-type natriuretic peptide a clinically useful biomarker of volume overload in peritoneal dialysis patients?
    Papakrivopoulou E; Lillywhite S; Davenport A
    Nephrol Dial Transplant; 2012 Jan; 27(1):396-401. PubMed ID: 21765049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of volume overload by bioelectrical impedance analysis, NT-proBNP and inferior vena cava diameter in patients with stage 3&4 and 5 chronic kidney disease.
    Yilmaz Z; Yildirim Y; Oto F; Aydin FY; Aydin E; Kadiroglu AK; Yilmaz ME
    Ren Fail; 2014 May; 36(4):495-501. PubMed ID: 24456050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between arterial stiffness and fluid status in peritoneal dialysis patients.
    Kocyigit I; Sipahioglu MH; Orscelik O; Unal A; Celik A; Abbas SR; Zhu F; Tokgoz B; Dogan A; Oymak O; Kotanko P; Levin NW
    Perit Dial Int; 2014; 34(7):781-90. PubMed ID: 24385328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioimpedance spectroscopy-guided fluid management in peritoneal dialysis patients with residual kidney function: A randomized controlled trial.
    Yoon HE; Kwon YJ; Shin SJ; Lee SY; Lee S; Kim SH; Lee EY; Shin SK; Kim YS
    Nephrology (Carlton); 2019 Dec; 24(12):1279-1289. PubMed ID: 30706575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Significance of Phase Angle in Non-Dialysis CKD Stage 5 and Peritoneal Dialysis Patients.
    Han BG; Lee JY; Kim JS; Yang JW
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
    Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overhydration prevalence in peritoneal dialysis - A 2 year longitudinal analysis.
    Aguiar PV; Santos O; Teixeira L; Silva F; Azevedo P; Vidinha J; Ferrer F; Carvalho MJ; Cabrita A; Rodrigues A
    Nefrologia; 2015; 35(2):189-96. PubMed ID: 26300513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary observations on the association between serum IL-6 and hydration status and cardiovascular risk in patients treated with peritoneal dialysis.
    Sikorska D; Pawlaczyk K; Roszak M; Czepulis N; Oko A; Karczewski M; Breborowicz A; Witowski J
    Cytokine; 2016 Sep; 85():171-6. PubMed ID: 27371776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of serum soluble Klotho levels and residual diuresis and overhydration in peritoneal dialysis patients.
    Sikorska D; Pawlaczyk K; Baum E; Wanic-Kossowska M; Czepulis N; Łuczak J; Samborski W; Oko A
    Adv Clin Exp Med; 2019 Oct; 28(10):1345-1349. PubMed ID: 30868770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Routine Bioimpedance-Guided Fluid Management Provide Additional Benefit to Non-Anuric Peritoneal Dialysis Patients? Results from COMPASS Clinical Trial.
    Oh KH; Baek SH; Joo KW; Kim DK; Kim YS; Kim S; Oh YK; Han BG; Chang JH; Chung W; Na KY;
    Perit Dial Int; 2018; 38(2):131-138. PubMed ID: 29386302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.
    Davenport A
    Am J Nephrol; 2012; 36(4):371-6. PubMed ID: 23051933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients.
    Fahim MA; Hayen A; Horvath AR; Dimeski G; Coburn A; Johnson DW; Hawley CM; Campbell SB; Craig JC
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):620-9. PubMed ID: 25714960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional status and overhydration: can bioimpedance spectroscopy be useful in haemodialysis patients?
    Garagarza C; João-Matias P; Sousa-Guerreiro C; Amaral T; Aires I; Ferreira C; Jorge C; Gil C; Ferreira A
    Nefrologia; 2013; 33(5):667-74. PubMed ID: 24089158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low triiodothyronine is associated with elevation of N-terminal pro-brain natriuretic peptide (NT-proBNP) and mortality in dialysis patients.
    Prado-Uribe MDC; Ventura MD; Ávila-Díaz M; Mora CJ; Méndez-Durán A; Villanueva-Noches D; Cisneros A; Ilabaca B; Cueto-Manzano A; García-Contreras F; Lindholm B; García-López E; Paniagua R
    Nefrologia; 2017; 37(6):598-607. PubMed ID: 28755902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of dialysis type on biomarkers for cardiovascular diseases.
    Sahinarslan A; Güz G; Mutluay R; Okyay K; Demirtaş C; Paşaoğlu H; Yalçın R
    Turk Kardiyol Dern Ars; 2011 Sep; 39(6):456-62. PubMed ID: 21918314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.